Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RNASE4 |
| Upstream (Parents) |
|---|
| (<<) AQP3 → RNASE4 |
| (<<) CBS → RNASE4 |
| (<<) HSD11B1 → RNASE4 |
| (<<) HSD17B2 → RNASE4 |
| (<<) HYAL1 → RNASE4 |
| (<<) MT1F → RNASE4 |
| (<<) NNMT → RNASE4 |
| (<<) PNPLA3 → RNASE4 |
| (<<) SAA4 → RNASE4 |
| Downstream (Children) |
|---|
| RNASE4 → ACTG1 (>>) |
| RNASE4 → ALDOA (>>) |
| RNASE4 → ASTN2 (>>) |
| RNASE4 → ATP2A2 (>>) |
| RNASE4 → BDH1 (>>) |
| RNASE4 → BLNK (>>) |
| RNASE4 → CDCP1 (>>) |
| RNASE4 → CDK8 (>>) |
| RNASE4 → CSNK1D (>>) |
| RNASE4 → DUSP10 (>>) |
| RNASE4 → ELF4 (>>) |
| RNASE4 → FGFR2 (>>) |
| RNASE4 → GOT1 (>>) |
| RNASE4 → HGS (>>) |
| RNASE4 → HRAS (>>) |
| RNASE4 → KLF11 (>>) |
| RNASE4 → MMP19 (>>) |
| RNASE4 → NDOR1 (>>) |
| RNASE4 → NRG1 (>>) |
| RNASE4 → PABPC3 (>>) |
| RNASE4 → PIK3C2B (>>) |
| RNASE4 → RAC1 (>>) |
| RNASE4 → RDH16 (>>) |
| RNASE4 → RPS6KA1 (>>) |
| RNASE4 → RXRA (>>) |
| RNASE4 → SET (>>) |
| RNASE4 → SYK (>>) |
| RNASE4 → TSPO (>>) |
| RNASE4 → UAP1 (>>) |
| RNASE4 → YWHAB (>>) |
| RNASE4 → ZBED2 (>>) |
